Petra Korpisalo-Pirinen

EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF

Groppa, E; Brkic, S; Uccelli, A; Wirth, G; Korpisalo-Pirinen, P; Filippova, M; Dasen. B; Sacchi, V; Muraro, MG; Trani, M; Reginato, S; Gianni-Barrera, R; Ylä-Herttuala, S; Banfi, A. 2018. Embo reports. 19: e45054 A1 Journal article (refereed), original research

T-2, T-1rho and T-RAFF4 detect early regenerative changes in mouse ischemic skeletal muscle

Laakso, Hanne; Wirth, Galina; Korpisalo, Petra; Ylä-Herttuala, Elias; Michaeli, Shalom; Ylä-Herttuala, Seppo; Liimatainen, Timo. 2018. Nmr in biomedicine. 31: e3909 A1 Journal article (refereed), original research

Angiogenic gene therapy in cardiovascular diseases: dream or vision?

Ylä-Herttuala S, Bridges C, Katz MG, Korpisalo P. 2017. European heart journal. 38: 1365-1371 A1 Journal article (refereed), original research

HIF-1 alpha and HIF-2 alpha induce angiogenesis and improve muscle energy recovery

Niemi Henna, Honkonen Krista, Korpisalo Petra, Huusko Jenni, Kansanen Emilia, Merentie Mari, Rissanen Tuomas T, André Helder, Pereira Teresa, Poellinger Lorenz, Alitalo Kari, Ylä-Herttuala Seppo. 2014. European journal of clinical investigation. 44: 989-999 A1 Journal article (refereed), original research

Ultrasound imaging with bolus delivered contrast agent for the detection of angiogenesis and blood flow irregularities

Korpisalo P, Hytönen JP, Laitinen JT, Närväinen J, Rissanen TT, Gröhn OH, Ylä-Herttuala S. 2014. American journal of physiology : heart and circulatory physiology. 307: H1226-H1232 A1 Journal article (refereed), original research

Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial

Gomes RS, das Neves RP, Cochlin L, Lima A, Carvalho R, Korpisalo P, Dragneva G, Turunen M, Liimatainen T, Clarke K, Ylä-Herttuala S, Carr C, Ferreira L. 2013. Acs nano. : 3362-72 A1 Journal article (refereed), original research

Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success

Dragneva G, Korpisalo P, Ylä-Herttuala S. 2013. Disease models and mechanisms. : 312-22 A2 Review article, Literature review, Systematic review

Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis

Anisimov A, Tvorogov D, Alitalo A, Leppänen VM, An Y, Han EC, Orsenigo F, Gaál EI, Holopainen T, Koh YJ, Tammela T, Korpisalo P, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Dejana E, Koh GY, Choi C, Saharinen P, Alitalo K. 2013. Circulation. : 424-34 A1 Journal article (refereed), original research

Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy

Korpisalo P, Hytönen JP, Laitinen JT, Laidinen S, Parviainen H, Karvinen H, Siponen J, Marjomäki V, Vajanto I, Rissanen TT, Ylä-Herttuala S.. 2011. European heart journal. 32: 1664-1672 A1 Journal article (refereed), original research

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

Karvinen H, Pasanen E, Rissanen T, Korpisalo P, Vähäkangas E, Jazwa A, Giacca M, Ylä-Herttuala S.. 2011. Gene therapy. 18: 1166-1172 A1 Journal article (refereed), original research

Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle

Anisimov A, Alitalo A, Korpisalo P, Soronen J, Kaijalainen S, Leppänen V-M, Jeltsch M, Ylä-Herttuala S, Alitalo K. 2009. Circulation research. 104: 1302-1312 A1 Journal article (refereed), original research

Angiogenic Gene Therapy. Vascular Endothelial Growth Factors and Platelet Derived Growth Factors in Vascular Growth and Stabilization

Korpisalo-Pirinen P. 2009. Kuopion yliopiston julkaisuja G.- A.I. Virtanen -instituutti G5 Doctoral dissertation (article)

Antegrade flow and peripheral resistance determine the level of endogenous arteriogenesis in patients with superficial femoral artery occlusion

Vajanto I, Korpisalo P, Karjalainen J, Hakala T, Mäkinen K, Ylä-Herttuala S. 2009. European journal of clinical investigation. 39: 1048-1054 A1 Journal article (refereed), original research

Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy

Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, Girnary R, Glass CK, Väisänen S, Ylä-Herttuala S. 2009. Circulation research. 105: 604-609 A1 Journal article (refereed), original research

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms

Lähteenvuo JE, Lähteenvuo MT, Kivelä A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vähäkangas E, Korpisalo P, Enholm B, Carmeliet P, Alitalo K, Eriksson U, Ylä-Herttuala S. 2009. Circulation. 119: 845-856 A1 Journal article (refereed), original research

High-resolution ultrasound perfusion imaging of therapeutic angiogenesis

Rissanen TT, Korpisalo P, Karvinen H, Liimatainen T, Laidinen S, Gröhn OH, Ylä-Herttuala S. 2008. JACC : cardiovascular imaging. 1: 83 - 91 A1 Journal article (refereed), original research

Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs

Korpisalo P, Rissanen TT, Bengtsson T, Liimatainen T, Laidinen S, Karvinen H, Markkanen JE, Gröhn OH, Ylä-Herttuala S. 2008. Cardiovascular research. 80: 263-270 A1 Journal article (refereed), original research

Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic

Korpisalo P, Karvinen H, Rissanen TT, Kilpijoki J, Marjomäki V, Baluk P, McDonald DM, Cao Y, Eriksson U, Alitalo K, Ylä-Herttuala S. 2008. Circulation research. 103: 1092-1099 A1 Journal article (refereed), original research

Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle

Kholová I, Koota S, Kaskenpää N, Leppänen P, Närväinen J, Kavec M, Rissanen TT, Hazes T, Korpisalo P, Gröhn O, Ylä-Herttuala S. 2007. Human gene therapy. 18: 232-244 A1 Journal article (refereed), original research

The strengths and weaknesses of VEGF adenovirus-driven angiogenesis

Korpisalo P, Rissanen TT, Ylä-Herttuala S. Teoksessa: Deindl E, Kupatt C(toim.) , 2007. Therapeutic Neovascularization - Quo Vadis?. s. 23-32. Springer A3 Book section, Chapters in research books

Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer

Kinnunen K, Korpisalo P, Rissanen TT, Heikura T, Viita H, Uusitalo H, Ylä-Herttuala S. 2006. Acta physiologica. 187: 447-457 A1 Journal article (refereed), original research

Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis

Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Ordén M-R, Kholová I, de Goede A, Heikura T, Gröhn OH, Ylä-Herttuala S. 2005. Circulation. 112: 3937-3946 A1 Journal article (refereed), original research

Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer

Pajusola K, Künnapuu J, Vuorikoski S, Soronen J, André H, Pereira T, Korpisalo P, Ylä-Herttuala S, Poellinger L, Alitalo K. 2005. Faseb journal. 19: 1365-1367 A1 Journal article (refereed), original research

Refine your search

Petra Korpisalo-Pirinen

Publications

EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF

T-2, T-1rho and T-RAFF4 detect early regenerative changes in mouse ischemic skeletal muscle

Angiogenic gene therapy in cardiovascular diseases: dream or vision?

HIF-1 alpha and HIF-2 alpha induce angiogenesis and improve muscle energy recovery

Ultrasound imaging with bolus delivered contrast agent for the detection of angiogenesis and blood flow irregularities

Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial

Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success

Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis

Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle

Angiogenic Gene Therapy. Vascular Endothelial Growth Factors and Platelet Derived Growth Factors in Vascular Growth and Stabilization

Antegrade flow and peripheral resistance determine the level of endogenous arteriogenesis in patients with superficial femoral artery occlusion

Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms

High-resolution ultrasound perfusion imaging of therapeutic angiogenesis

Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs

Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic

Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle

The strengths and weaknesses of VEGF adenovirus-driven angiogenesis

Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer

Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis

Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer